These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16490517)

  • 1. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Jonas JB; Kreissig I; Spandau UH; Harder B
    Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Lorenzo Carrero J; Pérez Flores I; González Barcia M
    Am J Ophthalmol; 2006 Sep; 142(3):529; author reply 529-30. PubMed ID: 16935616
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular availability of triamcinolone acetonide after intravitreal injection.
    Jonas JB
    Am J Ophthalmol; 2004 Mar; 137(3):560-2. PubMed ID: 15013884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cataract surgery after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring RF
    Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
    Jonas JB; Degenring R; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Dec; 138(6):1054-5. PubMed ID: 15629306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravitreal application of triamcinolone--our experiences].
    Konjević Pernar S; Vatavuk Z; Bencić G; Pentz A; Mandić Z
    Acta Med Croatica; 2006; 60(2):133-5. PubMed ID: 16848205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T; Uemura A; Kita H; Sakamoto T
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
    Roth DB; Chieh J; Spirn MJ; Green SN; Yarian DL; Chaudhry NA
    Arch Ophthalmol; 2003 Sep; 121(9):1279-82. PubMed ID: 12963610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Budde WM; Degenring RF
    Eur J Ophthalmol; 2005; 15(3):329-35. PubMed ID: 15945000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.